RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood disorder: daratumumab trial targets refractory aplastic anemia
Disease control Not yet recruitingThis study tests a drug called daratumumab in people with aplastic anemia that hasn't improved with standard treatments. The goal is to see if it is safe and can help the body make more blood cells. About 37 participants will receive multiple doses, and researchers will check for…
Matched conditions: RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New study aims to catch pancreatic cancer recurrence early
Knowledge-focused Not yet recruitingThis study looks at whether tumor cells found in the portal vein (a major liver blood vessel) can warn early if pancreatic cancer comes back or spreads. Researchers will test 20 people with removable or borderline-removable pancreatic cancer. The goal is to improve monitoring and…
Matched conditions: RELAPSE
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
New blood test could predict transplant complications early
Knowledge-focused Not yet recruitingThis study tests a new, standardized way to measure a type of immune cell called iNKT in the blood of 75 patients who have had a stem cell transplant for leukemia. The goal is to see if the levels of these cells can help predict serious complications like graft-versus-host diseas…
Matched conditions: RELAPSE
Sponsor: University Hospital Pilsen • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC